Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BIO Preparing For Human Subject Protection Provisions In FDA Bills

Executive Summary

The Biotechnology Industry Organization is preparing for the inclusion of human subject protection provisions in FDA bills scheduled for action in 2002.
Advertisement

Related Content

BIO Should Raise "Competing Moral Issues" In Cloning Debate - Feldbaum
BIO Should Raise "Competing Moral Issues" In Cloning Debate - Feldbaum
PhRMA Scurries To Prepare For PDUFA: Currie Moves Up To Chief Lobbyist
PhRMA Scurries To Prepare For PDUFA: Currie Moves Up To Chief Lobbyist
Gene Therapy Trials Could Be Halted If Public Disclosure Is Not Made - FDA
BIO VP-Government Relations Rawls Has Been Frist Chief Of Staff For 4 Years
BIO VP-Government Relations Rawls Has Been Frist Chief Of Staff For 4 Years
Advertisement
UsernamePublicRestriction

Register

PS037501

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel